STOK – Stoke Therapeutics Inc.

STOK — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

29.03

Margin Of Safety %

-26

Put/Call OI Ratio

1.66

EPS Next Q Diff

0.16

EPS Last/This Y

-3.25

EPS This/Next Y

0.19

Price

33.85

Target Price

45.1

Analyst Recom

Performance Q

3.78

Upside

-105.8%

Beta

1.31

Ticker: STOK

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	STOK	38.31	0.40	0.09	2856
2026-03-10	STOK	38.41	0.37	1.14	2958
2026-03-11	STOK	38	0.38	0.00	2931
2026-03-12	STOK	36.45	0.38	0.11	2933
2026-03-13	STOK	36.48	0.38	0.11	2933
2026-03-17	STOK	32.8	0.45	0.12	3369
2026-03-18	STOK	30.97	0.44	0.64	3452
2026-03-19	STOK	33.2	0.44	0.71	3437
2026-03-20	STOK	33.55	0.44	0.11	3457
2026-03-23	STOK	33.37	0.35	0.44	2226
2026-03-24	STOK	32.12	0.36	0.88	2316
2026-03-25	STOK	33.79	0.36	0.24	2335
2026-03-26	STOK	33.73	0.36	25.38	2395
2026-03-27	STOK	32.87	1.46	2.25	4486
2026-03-30	STOK	31.74	1.47	1.15	4527
2026-03-31	STOK	32.55	1.48	0.14	4565
2026-04-01	STOK	32.02	1.47	16.00	4588
2026-04-02	STOK	32.69	1.64	5.08	4960
2026-04-06	STOK	32.83	1.67	0.33	5004
2026-04-07	STOK	33.83	1.66	5.50	5027
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	STOK	38.34	-308.9	-	0.05
2026-03-10	STOK	38.38	-308.9	-	0.05
2026-03-11	STOK	37.90	-308.9	-	0.05
2026-03-12	STOK	36.44	-308.9	-	0.05
2026-03-13	STOK	33.23	-308.9	-	0.05
2026-03-17	STOK	32.80	-308.9	-	0.05
2026-03-18	STOK	30.99	-138.9	-	-3.12
2026-03-19	STOK	33.16	-138.9	-	-3.12
2026-03-20	STOK	33.51	-142.2	-	-3.33
2026-03-23	STOK	33.39	-142.2	-	-3.33
2026-03-24	STOK	32.18	-142.9	-	-3.37
2026-03-25	STOK	33.75	-142.9	-	-3.37
2026-03-26	STOK	33.73	-142.9	-	-3.37
2026-03-27	STOK	32.86	-142.9	-	-3.37
2026-03-30	STOK	31.74	-142.9	-	-3.37
2026-03-31	STOK	32.53	-142.9	-	-3.37
2026-04-01	STOK	31.97	-142.9	-	-3.37
2026-04-02	STOK	32.73	-142.9	-	-3.37
2026-04-06	STOK	32.79	-142.9	-	-3.37
2026-04-07	STOK	33.85	-142.9	-	-3.37
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	STOK	-1.83	11.56	26.52
2026-03-10	STOK	-1.83	11.56	26.52
2026-03-11	STOK	-1.83	11.56	27.86
2026-03-12	STOK	-2.12	11.56	27.86
2026-03-13	STOK	-2.12	11.56	27.86
2026-03-17	STOK	-2.12	11.55	27.86
2026-03-18	STOK	-2.12	11.55	27.86
2026-03-19	STOK	-2.05	11.55	26.90
2026-03-20	STOK	-2.28	11.55	26.90
2026-03-23	STOK	-2.28	11.12	26.90
2026-03-24	STOK	-2.35	11.12	26.90
2026-03-25	STOK	-2.35	11.12	29.03
2026-03-26	STOK	-2.35	11.12	29.03
2026-03-27	STOK	-2.35	11.12	29.03
2026-03-30	STOK	-2.35	11.12	29.03
2026-03-31	STOK	-2.35	11.12	29.03
2026-04-01	STOK	-2.35	11.12	29.03
2026-04-02	STOK	-2.35	11.12	29.03
2026-04-06	STOK	-2.32	11.11	29.03
2026-04-07	STOK	-2.32	11.11	29.03
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.97

Avg. EPS Est. Current Quarter

-0.82

Avg. EPS Est. Next Quarter

-0.81

Insider Transactions

-2.32

Institutional Transactions

11.11

Beta

1.31

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

25.01

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

18.6

Max Drawdown 5-Year %

-91.8

Target Price

45.1

P/E

Forward P/E

PEG

P/S

10.83

P/B

5.65

P/Free Cash Flow

44.49

EPS

-0.15

Average EPS Est. Cur. Y

-3.37

EPS Next Y. (Est.)

-3.18

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.73

Relative Volume

0.58

Return on Equity vs Sector %

-29.4

Return on Equity vs Industry %

-12.9

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.26

EBIT Estimation

◆ STOK Healthcare

$33.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

21/25

Volume

11/15

Valuation

9/20

TP/AR

4/10

Options

1/10

RSI

51.7

Range 1M

34.4%

Sup Dist

4.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

5/30

Estimates

4/20

Inst/Vol

7/15

Options

2/10

EPS Yr

-2715.3%

EPS NY

6.4%

52W%

80.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -2.2% upside

Quality

6/30

Valuation

1/30

Growth

3/25

Stability

8/10

LT Trend

3/5

Upside

-2.2%

Quality

MoS

-26%

Stoke Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 170

Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in Phase 1 clinical trials for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase 3 clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.

STOK

Latest News

—

Caricamento notizie per STOK…

stock quote shares STOK – Stoke Therapeutics Inc. Stock Price stock today

news today STOK – Stoke Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch STOK – Stoke Therapeutics Inc. yahoo finance google finance

stock history STOK – Stoke Therapeutics Inc. invest stock market

stock prices STOK premarket after hours

ticker STOK fair value insiders trading

STOK – Stoke Therapeutics, Inc.

STOK — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

29.03

Margin Of Safety %

-26

Put/Call OI Ratio

1.66

EPS Next Q Diff

0.16

EPS Last/This Y

-3.25

EPS This/Next Y

0.19

Price

33.85

Target Price

45.1

Analyst Recom

Performance Q

3.78

Upside

-105.8%

Beta

1.31

Ticker: STOK

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	STOK	38.31	0.40	0.09	2856
2026-03-10	STOK	38.41	0.37	1.14	2958
2026-03-11	STOK	38	0.38	0.00	2931
2026-03-12	STOK	36.45	0.38	0.11	2933
2026-03-13	STOK	36.48	0.38	0.11	2933
2026-03-17	STOK	32.8	0.45	0.12	3369
2026-03-18	STOK	30.97	0.44	0.64	3452
2026-03-19	STOK	33.2	0.44	0.71	3437
2026-03-20	STOK	33.55	0.44	0.11	3457
2026-03-23	STOK	33.37	0.35	0.44	2226
2026-03-24	STOK	32.12	0.36	0.88	2316
2026-03-25	STOK	33.79	0.36	0.24	2335
2026-03-26	STOK	33.73	0.36	25.38	2395
2026-03-27	STOK	32.87	1.46	2.25	4486
2026-03-30	STOK	31.74	1.47	1.15	4527
2026-03-31	STOK	32.55	1.48	0.14	4565
2026-04-01	STOK	32.02	1.47	16.00	4588
2026-04-02	STOK	32.69	1.64	5.08	4960
2026-04-06	STOK	32.83	1.67	0.33	5004
2026-04-07	STOK	33.83	1.66	5.50	5027
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	STOK	38.34	-308.9	-	0.05
2026-03-10	STOK	38.38	-308.9	-	0.05
2026-03-11	STOK	37.90	-308.9	-	0.05
2026-03-12	STOK	36.44	-308.9	-	0.05
2026-03-13	STOK	33.23	-308.9	-	0.05
2026-03-17	STOK	32.80	-308.9	-	0.05
2026-03-18	STOK	30.99	-138.9	-	-3.12
2026-03-19	STOK	33.16	-138.9	-	-3.12
2026-03-20	STOK	33.51	-142.2	-	-3.33
2026-03-23	STOK	33.39	-142.2	-	-3.33
2026-03-24	STOK	32.18	-142.9	-	-3.37
2026-03-25	STOK	33.75	-142.9	-	-3.37
2026-03-26	STOK	33.73	-142.9	-	-3.37
2026-03-27	STOK	32.86	-142.9	-	-3.37
2026-03-30	STOK	31.74	-142.9	-	-3.37
2026-03-31	STOK	32.53	-142.9	-	-3.37
2026-04-01	STOK	31.97	-142.9	-	-3.37
2026-04-02	STOK	32.73	-142.9	-	-3.37
2026-04-06	STOK	32.79	-142.9	-	-3.37
2026-04-07	STOK	33.85	-142.9	-	-3.37
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	STOK	-1.83	11.56	26.52
2026-03-10	STOK	-1.83	11.56	26.52
2026-03-11	STOK	-1.83	11.56	27.86
2026-03-12	STOK	-2.12	11.56	27.86
2026-03-13	STOK	-2.12	11.56	27.86
2026-03-17	STOK	-2.12	11.55	27.86
2026-03-18	STOK	-2.12	11.55	27.86
2026-03-19	STOK	-2.05	11.55	26.90
2026-03-20	STOK	-2.28	11.55	26.90
2026-03-23	STOK	-2.28	11.12	26.90
2026-03-24	STOK	-2.35	11.12	26.90
2026-03-25	STOK	-2.35	11.12	29.03
2026-03-26	STOK	-2.35	11.12	29.03
2026-03-27	STOK	-2.35	11.12	29.03
2026-03-30	STOK	-2.35	11.12	29.03
2026-03-31	STOK	-2.35	11.12	29.03
2026-04-01	STOK	-2.35	11.12	29.03
2026-04-02	STOK	-2.35	11.12	29.03
2026-04-06	STOK	-2.32	11.11	29.03
2026-04-07	STOK	-2.32	11.11	29.03
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.97

Avg. EPS Est. Current Quarter

-0.82

Avg. EPS Est. Next Quarter

-0.81

Insider Transactions

-2.32

Institutional Transactions

11.11

Beta

1.31

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

25.01

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

18.6

Max Drawdown 5-Year %

-91.8

Target Price

45.1

P/E

Forward P/E

PEG

P/S

10.83

P/B

5.65

P/Free Cash Flow

44.49

EPS

-0.15

Average EPS Est. Cur. Y

-3.37

EPS Next Y. (Est.)

-3.18

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-3.73

Relative Volume

0.58

Return on Equity vs Sector %

-29.4

Return on Equity vs Industry %

-12.9

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.26

EBIT Estimation

◆ STOK Healthcare

$33.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

21/25

Volume

11/15

Valuation

9/20

TP/AR

4/10

Options

1/10

RSI

51.7

Range 1M

34.4%

Sup Dist

4.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

5/30

Estimates

4/20

Inst/Vol

7/15

Options

2/10

EPS Yr

-2715.3%

EPS NY

6.4%

52W%

80.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -2.2% upside

Quality

6/30

Valuation

1/30

Growth

3/25

Stability

8/10

LT Trend

3/5

Upside

-2.2%

Quality

MoS

-26%

Stoke Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 170

STOK

Latest News

—

Caricamento notizie per STOK…

stock quote shares STOK – Stoke Therapeutics, Inc. Stock Price stock today

news today STOK – Stoke Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch STOK – Stoke Therapeutics, Inc. yahoo finance google finance

stock history STOK – Stoke Therapeutics, Inc. invest stock market

stock prices STOK premarket after hours

ticker STOK fair value insiders trading

STOK – Stoke Therapeutics Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: STOK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

STOK – Stoke Therapeutics, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: STOK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y